Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...
Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds ...
CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its ...
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...
So what’s in your crisper drawer? If it’s like mine — that’s where I store all the leftovers — things that don’t have a designated place in my fridge. Things like an open package of sliced meat, odd ...
Founded in 2020, CrisprBits operates in the biotechnology space and provides CRISPR-based genomic editing solutions. Initially focusing on developing precise gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback